Jim Simons Renovo Rx, Inc. Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q2 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 251,800 shares of RNXT stock, worth $317,268. This represents 0.0% of its overall portfolio holdings.
Number of Shares
251,800
Previous 27,656
810.47%
Holding current value
$317,268
Previous $27,000
1129.63%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RNXT
# of Institutions
28Shares Held
9.77MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD3.47MShares$4.37 Million2.59% of portfolio
-
Awm Investment Company, Inc. New York, NY1.87MShares$2.36 Million0.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$2.1 Million0.0% of portfolio
-
Bank Of The West975KShares$1.23 Million0.27% of portfolio
-
Bleichroeder LP New York, NY500KShares$630,0000.21% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $11.4M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...